These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12837675)

  • 21. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy.
    Winblad B; Wimo A; Engedal K; Soininen H; Verhey F; Waldemar G; Wetterholm AL; Haglund A; Zhang R; Schindler R
    Dement Geriatr Cogn Disord; 2006; 21(5-6):353-63. PubMed ID: 16508298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome.
    Hemingway-Eltomey JM; Lerner AJ
    Am J Psychiatry; 1999 Sep; 156(9):1470. PubMed ID: 10484967
    [No Abstract]   [Full Text] [Related]  

  • 23. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease.
    Marinho V; Laks J; Engelhardt E; Conn D
    J Clin Psychopharmacol; 2006 Dec; 26(6):683-5. PubMed ID: 17110839
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agitation in Alzheimer's disease: no to donepezil. Psycho-behavioural measures are better option.
    Prescrire Int; 2008 Oct; 17(97):212. PubMed ID: 19536942
    [No Abstract]   [Full Text] [Related]  

  • 26. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil-related toxic hepatitis.
    Dierckx RI; Vandewoude MF
    Acta Clin Belg; 2008; 63(5):339-42. PubMed ID: 19186568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case report: Post-traumatic memories triggered by donepezil in a dose-dependent pattern.
    Wolff ML
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):219-22. PubMed ID: 22445625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease.
    Ritchie CW; Ames D; Clayton T; Lai R
    Am J Geriatr Psychiatry; 2004; 12(4):358-69. PubMed ID: 15249273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of neuropsychiatric symptoms in patients with dementia.
    Yaffe K
    N Engl J Med; 2007 Oct; 357(14):1441-3. PubMed ID: 17914047
    [No Abstract]   [Full Text] [Related]  

  • 31. [Many Alzheimer patients untreated].
    MMW Fortschr Med; 2002 Oct; 144(40):51. PubMed ID: 12449096
    [No Abstract]   [Full Text] [Related]  

  • 32. Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in Germany.
    Froelich L; Gertz HJ; Heun R; Heuser I; Jendroska K; Kornhuber J; Kurz A; Mueller-Thomsen T; Ries F; Waechtler C; Metz M; Goebel C
    Dement Geriatr Cogn Disord; 2004; 18(1):37-43. PubMed ID: 15084792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
    Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.
    Starr JM
    J Am Geriatr Soc; 2007 May; 55(5):800-1. PubMed ID: 17493206
    [No Abstract]   [Full Text] [Related]  

  • 36. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
    Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
    Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
    [No Abstract]   [Full Text] [Related]  

  • 38. Donepezil use in Alzheimer disease.
    Barner EL; Gray SL
    Ann Pharmacother; 1998 Jan; 32(1):70-7. PubMed ID: 9475825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donepezil: syncope. Various cardiac disorders.
    Prescrire Int; 2008 Jun; 17(95):113. PubMed ID: 18630357
    [No Abstract]   [Full Text] [Related]  

  • 40. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.
    Prasher VP; Adams C; Holder R;
    Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.